Cargando...

A genetic risk score composed of rheumatoid arthritis risk alleles, HLA-DRB1 haplotypes, and response to TNFi therapy – results from a Swedish cohort study

BACKGROUND: To prevent debilitating and irreversible joint damage, rheumatoid arthritis (RA) is often treated with tumor necrosis factor inhibitor (TNFi), but many patients do not respond to this costly therapy. Few predictors for response are known, and it has been proposed that genetic factors whi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Arthritis Res Ther
Autores principales: Jiang, Xia, Askling, Johan, Saevarsdottir, Saedis, Padyukov, Leonid, Alfredsson, Lars, Viatte, Sebastien, Frisell, Thomas
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5135751/
https://ncbi.nlm.nih.gov/pubmed/27912794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-016-1174-z
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!